| View |
|
DRP-10814
|
Multivitamins + Minerals
|
Golvate
|
Formulation Each film-coated tablet contains:
Ascorbic Acid, USP-85mg d-Alpha-Tocopheryl Acetate (Vitamin E), USP-21IU Niacinamide (Vitamin B1), USP-18mg Calcuum Pantothenate (Vitamin B1), USP-6mg Cholecalciferol (Vitamin D1), USP-200IU Pyridoxine Hydrochloride (Vitamin B6), USP-200IU Thiamine Mononitrate (Vitamin B1), USP-1.9mg Riboflavine-5-Phosphate Sadium (Vitamin B1),USP-1.4mg Folic Acid, USP-800mcg
Cyanexohalamin (Vitamin B12), USP-2.6mcg Calcium (as Calcium Carbonate and Calcium Hydrogen Phosphate Anhydrous), USP-125mg trou (equivalent to 182 5440mg Famous Fumarate), USP-60mg Magnesium (equivalent to 165.x5mg Magnesium Oxide), USP-50mg Zinc (equivalent to 13.6873mg Zinc Oxide), USP-11mg Manganese (equivalait to 5.8452mg Manganese Sulfate Monohydrate), USP-1.90mcg Copper (equivalent to 2.6373mg Copper Sulfate Pantalıydrate), USP-1mg Modane (quivalent to 0,3022mg Potassium Iodide), USP-220mcg Sellenken (equivaleant to 0.1205mg Sodiun Scante), USP-50mcg
|
Film Coated Tablet
|
Vitamins / Minerals
|
Phil. United Pharma Corp. (PUPC)
|
Philippines
|
Initial [OTC]
|
29 November 2021
|
29 November 2026
|
| View |
|
DRP-5390-06
|
Mefenamic Acid
|
Mefenak
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
25 July 2024
|
11 July 2029
|
| View |
|
DRP-4496-06
|
Mefenamic Acid
|
Mefenak
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
25 July 2023
|
02 July 2028
|
| View |
|
DRP-5390-07
|
Mefenamic Acid
|
Meferap
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
11 July 2024
|
11 July 2029
|
| View |
|
DRP-4496-07
|
Mefenamic Acid
|
Meferap
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
25 July 2023
|
02 July 2028
|
| View |
|
DRP-4496-08
|
Mefenamic Acid
|
Mefnak
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
25 July 2023
|
02 July 2028
|
| View |
|
DRP-8990-02
|
Sevoflurane
|
Nishaflurane
|
100 % v/v
|
Volatile Liquid For Inhalation
|
-
|
Lunan Better Pharmaceutical Co., Ltd.
|
Philippines
|
-
|
26 November 2021
|
23 July 2025
|
| View |
|
DRP-4067-03
|
Cetirizine Hydrochloride
|
Sitrizine
|
2.5 mg/ mL
|
Syrup (Oral Drops)
|
Antihistamine (Piperazine Derivative)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
07 October 2022
|
19 October 2027
|
| View |
|
DRP-9356-01
|
Hyoscine-N-Butylbromide
|
Iscopan
|
20 mg/mL
|
Solution for Injection (IM/IV/SC)
|
-
|
Farbe Firma
|
India
|
Initial (Reissuance)
|
29 July 2022
|
11 December 2025
|
| View |
|
DRP-10817
|
Ascorbic Acid + Zinc
|
None
|
100 mg/10 mg (equivalent to 27.45 mg Zinc Sulfate
Monohydrate) per 5 mL (Orange Flavor)
|
Syrup
|
Vitamin / Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial (PCPR)
|
01 December 2021
|
01 December 2026
|
| View |
|
DRP-292-04
|
Erythromycin
|
Neonate
|
5 mg/g (0.5%)
|
Ophthalmic Ointment
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
24 November 2021
|
23 June 2026
|
| View |
|
DRP-10800
|
Clotrimazole
|
Trimaxol
|
10 mg/g (1% w/w)
|
Topical Cream
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial OTC]
|
25 August 2022
|
24 November 2026
|
| View |
|
DRP-10049-01
|
Tranexamic Acid + Mefenamic Acid
|
Traxan Plus
|
500 mg/250 mg
|
Film coated tablet
|
-
|
Concept Pharmaceuticals Ltd.
|
India
|
-
|
26 November 2021
|
02 December 2024
|
| View |
|
DRP-10794
|
Isosorbide Mononitrate
|
Saphorbide-30
|
30 mg
|
Prolonged-Release Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
-
|
24 November 2021
|
24 November 2026
|
| View |
|
DRP-2401-05
|
Doxycycline (As Hyclate)
|
Pyrodoxy
|
100 mg
|
Capsule
|
Antibacterial (Tetracycline)
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP
|
24 November 2021
|
19 August 2025
|
| View |
|
DRP-991-09
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B + Cyanocobalamin
(Vitamin B12)
|
Neurofron Forte
|
500 mg/250 mg/1 mg
|
Film-Coated Tablet
|
Vitamin
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 June 2023
|
22 May 2028
|
| View |
|
DRP-8581-02
|
Docetaxel
|
Taxogen
|
40 mg/mL (20 mg/0.5 mL)
|
Concentrate Solution for IV
Infusion
|
Antineoplastic
|
Venus Remedies, Limited
|
India
|
CLIDP
|
24 November 2021
|
18 December 2024
|
| View |
|
DRP-8580-02
|
Docetaxel
|
Taxogen
|
40 mg/mL (80 mg/2 mL)
|
Concentrate Solution for IV
Infusion
|
-
|
Venus Remedies, Limited
|
India
|
-
|
24 November 2021
|
18 December 2024
|
| View |
|
DRP-3549-04
|
Azithromycin (as Dihydrate)
|
None
|
500 mg
|
Film-Coated Tablet
|
-
|
Hizon Laboratories, Inc
|
Philippines
|
-
|
24 November 2021
|
16 September 2026
|
| View |
|
DRP-1695-01
|
Meloxicam
|
Cloxim
|
15 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID
|
Drugmaker's Laboratories, Inc.,
|
Philippines
|
Automatic Renewal
|
25 November 2021
|
11 February 2026
|